EuBiologics Co., Ltd. (206650.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap416.59B
Enterprise Value396.92B
P/E Ratio10.94
PEG Ratio-0.28
Price/Sales Ratio2.6
Price/Book Ratio1.75
Enterprise/Revenue2.52
Enterprise/EBITDA5.39

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.24
Operating Margin0.35
AD

Management Effectiveness

Return On Assets0.12
Return On Equity0.16

Income Statement

Revenue149.2B
Revenue/Share3,329.9
Gross Profit85.35B
EBITDA70.66B
Net Income41.26B
Diluted EPS1,124.73

Balance Sheet

Total Cash66.36B
Total Cash/Share1,806.61
Total Debt3.66B
Total Debt/Equity0.02
Current Ratio3.97
Book Value Per Share4,941.86

Price History

52-Week Change-30.66
52-Week High17,700
52-Week Low6,950
Moving Average 50 Days8,562.8
Moving Average 200 Days11,600.4

Statistics

Average Volume197,820
Shares Outstanding36.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor517:500
Last Split DateNovember 12, 2020
AD